Moderna Inc. (MRNA) Thursday reported a fourth-quarter net loss that widened from last year. But quarterly revenues surged from the previous year, driven by increases in grant revenue and product sales. The company raised its 2021 COVID-19 vaccine manufacturing plan.
from RTT - Earnings https://ift.tt/3qVNYc7
via IFTTT
No comments:
Post a Comment